List of Excipients in API ASPIRIN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ASPIRIN
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| PLx Pharma Inc | VAZALORE | aspirin | 73089-081 | ANHYDROUS CITRIC ACID | 2032-09-29 |
| PLx Pharma Inc | VAZALORE | aspirin | 73089-081 | CARRAGEENAN | 2032-09-29 |
| PLx Pharma Inc | VAZALORE | aspirin | 73089-081 | FD&C BLUE NO. 1 | 2032-09-29 |
| PLx Pharma Inc | VAZALORE | aspirin | 73089-081 | HYPROMELLOSE | 2032-09-29 |
| PLx Pharma Inc | VAZALORE | aspirin | 73089-081 | LECITHIN, SOYBEAN | 2032-09-29 |
| PLx Pharma Inc | VAZALORE | aspirin | 73089-081 | OLEIC ACID | 2032-09-29 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ASPIRIN
Detailed excipient profiles for ASPIRIN
Excipient focus: .IOTA.-CARRAGEENAN
ASPIRIN drug variants containing .IOTA.-CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-325 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing .IOTA.-CARRAGEENAN
Excipient focus: ACACIA
ASPIRIN drug variants containing ACACIA
ASPIRIN drug variants not containing ACACIA
Excipient focus: ALCOHOL
ASPIRIN drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| Zydus Pharmaceuticals USA Inc | aspirin-dipyridamole | 68382-618 |
| Zydus Lifesciences Limited | aspirin-dipyridamole | 70771-1172 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing ALCOHOL
Excipient focus: ALGINIC ACID
ASPIRIN drug variants containing ALGINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | aspirin and extended - release dipyridamole | 0904-7056 |
| Par Pharmaceutical Inc | aspirin and extended - release dipyridamole | 49884-007 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing ALGINIC ACID
Excipient focus: ALUMINUM MONOSTEARATE
ASPIRIN drug variants containing ALUMINUM MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing ALUMINUM MONOSTEARATE
Excipient focus: ALUMINUM STEARATE
ASPIRIN drug variants containing ALUMINUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | aspirin and dipyridamole | 21695-656 |
| Physicians Total Care Inc | aspirin and dipyridamole | 54868-5143 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing ALUMINUM STEARATE
Excipient focus: AMMONIA
ASPIRIN drug variants containing AMMONIA
ASPIRIN drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
ASPIRIN drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
ASPIRIN drug variants containing ANHYDROUS LACTOSE
ASPIRIN drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYL ALCOHOL
ASPIRIN drug variants containing BUTYL ALCOHOL
ASPIRIN drug variants not containing BUTYL ALCOHOL
Excipient focus: CAPRYLIC/CAPRIC MONO/DIGLYCERIDES
ASPIRIN drug variants containing CAPRYLIC/CAPRIC MONO/DIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | aspirin and extended-release dipyridamole | 42571-274 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing CAPRYLIC/CAPRIC MONO/DIGLYCERIDES
Excipient focus: CARNAUBA WAX
ASPIRIN drug variants containing CARNAUBA WAX
ASPIRIN drug variants not containing CARNAUBA WAX
Excipient focus: CARRAGEENAN
ASPIRIN drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing CARRAGEENAN
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ASPIRIN drug variants containing CELLULOSE, MICROCRYSTALLINE
ASPIRIN drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| Major Pharmaceuticals | aspirin and extended - release dipyridamole | 0904-7056 |
| Par Pharmaceutical Inc | aspirin and extended - release dipyridamole | 49884-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
ASPIRIN drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing COPOVIDONE K25-31
Excipient focus: D&C YELLOW NO. 10
ASPIRIN drug variants containing D&C YELLOW NO. 10
ASPIRIN drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIMETHICONE
ASPIRIN drug variants containing DIMETHICONE
ASPIRIN drug variants not containing DIMETHICONE
Excipient focus: ETHYLCELLULOSE
ASPIRIN drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | aspirin and extended - release dipyridamole | 0904-7056 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing ETHYLCELLULOSE
Excipient focus: ETHYLCELLULOSES
ASPIRIN drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| Par Pharmaceutical Inc | aspirin and extended - release dipyridamole | 49884-007 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing ETHYLCELLULOSES
Excipient focus: FD&C BLUE NO. 1
ASPIRIN drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| Micro Labs Limited | aspirin and extended-release dipyridamole | 42571-274 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
ASPIRIN drug variants containing FD&C BLUE NO. 2
ASPIRIN drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
ASPIRIN drug variants containing FD&C RED NO. 40
ASPIRIN drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
ASPIRIN drug variants containing FD&C YELLOW NO. 6
ASPIRIN drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
ASPIRIN drug variants containing FERRIC OXIDE RED
ASPIRIN drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
ASPIRIN drug variants containing FERRIC OXIDE YELLOW
ASPIRIN drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| Zydus Pharmaceuticals USA Inc | aspirin-dipyridamole | 68382-618 |
| Zydus Lifesciences Limited | aspirin-dipyridamole | 70771-1172 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
ASPIRIN drug variants containing FERROSOFERRIC OXIDE
ASPIRIN drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
ASPIRIN drug variants containing GELATIN
ASPIRIN drug variants not containing GELATIN
Excipient focus: GLYCERYL MONOSTEARATE
ASPIRIN drug variants containing GLYCERYL MONOSTEARATE
ASPIRIN drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: HYDROGENATED CASTOR OIL
ASPIRIN drug variants containing HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | aspirin and extended-release dipyridamole | 51407-271 |
| Lannett Company Inc | aspirin and extended-release dipyridamole | 62175-330 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing HYDROGENATED CASTOR OIL
Excipient focus: HYPROMELLOSE
ASPIRIN drug variants containing HYPROMELLOSE
ASPIRIN drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
ASPIRIN drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
ASPIRIN drug variants containing HYPROMELLOSE 2910
ASPIRIN drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSE PHTHALATE
ASPIRIN drug variants containing HYPROMELLOSE PHTHALATE
ASPIRIN drug variants not containing HYPROMELLOSE PHTHALATE
Excipient focus: HYPROMELLOSES
ASPIRIN drug variants containing HYPROMELLOSES
ASPIRIN drug variants not containing HYPROMELLOSES
Excipient focus: INDIGOTINDISULFONATE SODIUM
ASPIRIN drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: ISOPROPYL ALCOHOL
ASPIRIN drug variants containing ISOPROPYL ALCOHOL
ASPIRIN drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
ASPIRIN drug variants containing LACTOSE MONOHYDRATE
ASPIRIN drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
ASPIRIN drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| NorthStar Rx LLC | aspirin and dipyridamole | 16714-964 |
| Dr Reddy's Laboratories Inc | aspirin and dipyridamole | 43598-339 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MALTODEXTRIN
ASPIRIN drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing MALTODEXTRIN
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
ASPIRIN drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
ASPIRIN drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
ASPIRIN drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
ASPIRIN drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
ASPIRIN drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | aspirin and extended-release dipyridamole | 65162-596 |
| Genus Lifesciences Inc | aspirin and omeprazole | 64950-424 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: OLEIC ACID
ASPIRIN drug variants containing OLEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing OLEIC ACID
Excipient focus: POLYDEXTROSE
ASPIRIN drug variants containing POLYDEXTROSE
ASPIRIN drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
ASPIRIN drug variants containing POLYETHYLENE GLYCOL
ASPIRIN drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
ASPIRIN drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOLS
ASPIRIN drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Aralez Pharmaceuticals Us Inc | aspirin and omeprazole | 70347-081 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
ASPIRIN drug variants containing POLYSORBATE 80
ASPIRIN drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
ASPIRIN drug variants containing POLYVINYL ALCOHOL
ASPIRIN drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POTASSIUM CHLORIDE
ASPIRIN drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing POTASSIUM CHLORIDE
Excipient focus: POTASSIUM HYDROXIDE
ASPIRIN drug variants containing POTASSIUM HYDROXIDE
ASPIRIN drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
ASPIRIN drug variants containing POVIDONE
ASPIRIN drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| Sun Pharmaceutical Industries Inc | aspirin and dipyridamole extended release | 47335-927 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
ASPIRIN drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing POVIDONE K25
Excipient focus: POVIDONE K90
ASPIRIN drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | aspirin and dipyridamole | 0093-3064 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing POVIDONE K90
Excipient focus: PROPYLENE GLYCOL
ASPIRIN drug variants containing PROPYLENE GLYCOL
ASPIRIN drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
ASPIRIN drug variants containing SHELLAC
ASPIRIN drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
ASPIRIN drug variants containing SILICON DIOXIDE
ASPIRIN drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
ASPIRIN drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | aspirin and extended-release dipyridamole | 42291-116 |
| ANI Pharmaceuticals Inc | aspirin and extended-release dipyridamole | 62559-850 |
| Amneal Pharmaceuticals LLC | aspirin and extended-release dipyridamole | 65162-596 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
ASPIRIN drug variants containing SODIUM LAURYL SULFATE
ASPIRIN drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
ASPIRIN drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
ASPIRIN drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SOYBEAN OIL
ASPIRIN drug variants containing SOYBEAN OIL
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| >Company | >Ingredient | >NDC |
ASPIRIN drug variants not containing SOYBEAN OIL
Excipient focus: STARCH, CORN
ASPIRIN drug variants containing STARCH, CORN
ASPIRIN drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| Micro Labs Limited | aspirin and extended-release dipyridamole | 42571-274 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
ASPIRIN drug variants containing STEARIC ACID
ASPIRIN drug variants not containing STEARIC ACID
Excipient focus: SUCROSE
ASPIRIN drug variants containing SUCROSE
ASPIRIN drug variants not containing SUCROSE
Excipient focus: TALC
ASPIRIN drug variants containing TALC
ASPIRIN drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| >Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
ASPIRIN drug variants containing TARTARIC ACID
ASPIRIN drug variants not containing TARTARIC ACID
Excipient focus: TITANIUM DIOXIDE
ASPIRIN drug variants containing TITANIUM DIOXIDE
ASPIRIN drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
ASPIRIN drug variants containing TRIACETIN
ASPIRIN drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| PLx Pharma Inc | aspirin | 73089-081 |
| PLx Pharma Inc | aspirin | 73089-325 |
| Zydus Pharmaceuticals USA Inc | aspirin-dipyridamole | 68382-618 |
| Zydus Lifesciences Limited | aspirin-dipyridamole | 70771-1172 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
ASPIRIN drug variants containing TRIETHYL CITRATE
ASPIRIN drug variants not containing TRIETHYL CITRATE
Excipient focus: WATER
ASPIRIN drug variants containing WATER
ASPIRIN drug variants not containing WATER
Excipient focus: XANTHAN GUM
ASPIRIN drug variants containing XANTHAN GUM
ASPIRIN drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
